A detailed history of Lion Street Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lion Street Advisors, LLC holds 5,112 shares of AZN stock, worth $324,049. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,112
Previous 3,462 47.66%
Holding current value
$324,049
Previous $270,000 47.41%
% of portfolio
0.14%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$76.67 - $87.62 $126,505 - $144,573
1,650 Added 47.66%
5,112 $398,000
Q2 2024

Jul 12, 2024

BUY
$66.81 - $80.83 $12,359 - $14,953
185 Added 5.65%
3,462 $270,000
Q4 2023

Jan 09, 2024

BUY
$61.89 - $69.28 $202,813 - $227,030
3,277 New
3,277 $220,000
Q2 2020

Jul 20, 2020

SELL
$43.1 - $55.31 $3,965 - $5,088
-92 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $3,476 - $4,722
92 New
92 $4,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.